Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
Janssen YJ, Helmerhorst F, Frölich M, Roelfsema F. Janssen YJ, et al. J Clin Endocrinol Metab. 2000 Jan;85(1):464-7. doi: 10.1210/jcem.85.1.6311. J Clin Endocrinol Metab. 2000. PMID: 10634425 Clinical Trial.
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass.
Smit JW, Janssen YJ, Lamb HJ, van der Wall EE, Stokkel MP, Viergever E, Biermasz NR, Bax JJ, Vliegen HW, de Roos A, Romijn JA, Roelfsema F. Smit JW, et al. Among authors: janssen yj. J Clin Endocrinol Metab. 2001 Oct;86(10):4638-43. doi: 10.1210/jcem.86.10.7832. J Clin Endocrinol Metab. 2001. PMID: 11600518 Clinical Trial.
Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F. Biermasz NR, et al. Among authors: janssen yj. J Clin Endocrinol Metab. 2001 Jul;86(7):3079-85. doi: 10.1210/jcem.86.7.7669. J Clin Endocrinol Metab. 2001. PMID: 11443170 Clinical Trial.
The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.
Janssen YJ, Frölich M, Roelfsema F. Janssen YJ, et al. Br J Clin Pharmacol. 1999 Mar;47(3):273-8. doi: 10.1046/j.1365-2125.1999.00892.x. Br J Clin Pharmacol. 1999. PMID: 10215751 Free PMC article. Clinical Trial.
Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency.
Janssen YJ, Doornbos J, Roelfsema F. Janssen YJ, et al. J Clin Endocrinol Metab. 1999 Jan;84(1):279-84. doi: 10.1210/jcem.84.1.5411. J Clin Endocrinol Metab. 1999. PMID: 9920096
Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
Janssen YJ, Hamdy NA, Frölich M, Roelfsema F. Janssen YJ, et al. J Clin Endocrinol Metab. 1998 Jun;83(6):2143-8. doi: 10.1210/jcem.83.6.4851. J Clin Endocrinol Metab. 1998. PMID: 9626153 Clinical Trial.
Serum leptin levels during recombinant human GH therapy in adults with GH deficiency.
Janssen YJ, Frölich M, Deurenberg P, Roelfsema F. Janssen YJ, et al. Eur J Endocrinol. 1997 Dec;137(6):650-4. doi: 10.1530/eje.0.1370650. Eur J Endocrinol. 1997. PMID: 9437231
A low starting dose of genotropin in growth hormone-deficient adults.
Janssen YJ, Frölich M, Roelfsema F. Janssen YJ, et al. J Clin Endocrinol Metab. 1997 Jan;82(1):129-35. doi: 10.1210/jcem.82.1.3669. J Clin Endocrinol Metab. 1997. PMID: 8989246 Clinical Trial.
Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults.
Janssen YJ, Deurenberg P, Roelfsema F. Janssen YJ, et al. J Clin Endocrinol Metab. 1997 Oct;82(10):3349-55. doi: 10.1210/jcem.82.10.4272. J Clin Endocrinol Metab. 1997. PMID: 9329367
Feedback